Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?

Oncology

Volumn 78, Issue SUPPL. 1, 2010, Pages 87-93

  Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dysplastic nodule; Early hepatocellular carcinoma; Gd EOB DTPA; Hepatocellular carcinoma; Liver tumor

Indexed keywords

CONTRAST MEDIUM; FERUCARBOTRAN; GADOXETIC ACID; ORGANIC ANION TRANSPORTER 1;

ALGORITHM; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG EXCRETION; DRUG UPTAKE; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING;

EID: 77954492830     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315235     Document Type: Review

References (22)

1. Van Montfoort JE, Stieger B, Meijer DK, et al: Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide OATP1. J Pharmacol Exp Ther 1999; 290: 153-157.
2. Pascolo L, Petrovic S, Cupelli F, et al: ABC protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. Biochem Biophys Res Commun 2001; 282: 60-66.
3. Narita M, Hatano E, Arizono S, et al: Expression of OATP1B3 determines uptake of Gb- EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009; 44: 793-798.
4. Kojiro M, Nakashima O: Histopathologic evaluation of hepatocellular carcinoma with a special reference to small early stage tumor. Semin Liver Dis 1999; 19: 287-296.
5. Kojiro M: Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West. Hepatol Res 2007; 37:S249-S252.
6. Nakano M, Saito A, Yamamoto M, et al: Stromal invasion and blood vessel wall invasion in well-differentiated hepatocellular carcinoma. Liver 1997; 17: 41-46.
7. Park YN, Kojiro M, Di Tommaso L, et al: Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 2007; 109: 915-923.
8. International Consensus Group for Hepatocellular Neoplasia: Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49: 658-664.
9. Desmet VJ: East-West pathology agreement on precancerous liver lesions and early hepatocellular carcinoma. Hepatology 2009; 49: 355-357.
10. Kudo M: The 2008 Okuda Lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol 2010; 25: 439-452.
11. Sano K, Ichikawa T, Matsuda M, et al: Usefulness of Gd-EOB-DTPA-enhanced MRI for detecting early hepatocellular carcinoma (in Japanese). Hepatobiliary Pancreat Imaging 2009; 11: 513-517.
12. Matsui O, Kadoya M, Kameyama T, et al: Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991; 178: 493-497.
13. Hayashi M, Matsui O, Ueda K, et al: Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR 1999; 72: 969-976.
14. Ueda K, Matsui O, Kawamori Y, et al: Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology 1998; 206: 161-166.
15. Kudo M: Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19: 297-309.
16. Kudo M: Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009; 44: 112-118.
17. Kim YK, Kwak HS, Kim CS, et al: Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2006; 238: 531-541.
18. Imai Y, Murakami T, Yoshida S, et al: Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000; 32: 205-212.
19. Kudo M, Hatanaka K, Maekawa K: Sonazoid- enhanced ultrasound in the diagnosis and treatment of hepatic tumors. J Med Ultrasound 2008; 16: 130-139.
20. Kudo M, Hatanaka K, Maekawa K: Defect reperfusion imaging, a newly developed novel technology using Sonazoid in the treatment of hepatocellular carcinoma. J Med Ultrasound 2008; 16: 169-176.
21. Kudo M, Okanoue T; Clinical Practice Manual of HCC Expert Panel: Management of hepatocellular carcinoma in Japan: consensus- based clinical practice manual proposed by the Japan Society of Hepatology (JSH). Oncology 2007; 72(suppl):2-15.
22. Kudo M: Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Oncology 2008; 75(suppl): 1-12.